167756-90-3

Basic information

• Product Name: Carbamic acid, [(3-aminophenyl)methyl]methyl-, 1,1-dimethylethyl ester
• Synonyms: tert-butyl 3-aminobenzyl(methyl)carbamate;(3-Amino-benzyl)-methyl-carbamic acid tert-butyl ester;3-(N-t-butoxycarbonyl-N-methylaminomethyl)aniline;3-(N-tert-butoxycarbonyl-N-methylaminomethyl)aniline;tert-butyl (3-aminobenzyl)methylcarbamate
• CAS NO: 167756-90-3
• Molecular Formula: C13H20N2O2
• Molecular Weight: 236.314
• Mol File: 167756-90-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 363.1±21.0 °C(Predicted)
• Density: 1.084±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Carbamic acid, [(3-aminophenyl)methyl]methyl-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(3-aminophenyl)methyl]methyl-, 1,1-dimethylethyl ester(167756-90-3)
• EPA Substance Registry System: Carbamic acid, [(3-aminophenyl)methyl]methyl-, 1,1-dimethylethyl ester(167756-90-3)

Safety Data

• Hazardous Substances Data: 167756-90-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 99-61-6 3-nitro-benzaldehyde 
• 3958-57-4 1-bromomethyl-3-nitrobenzene 
• 19499-61-7 methyl-(3-nitro-benzyl)-amine 
• 147291-65-4 N-(3-nitrophenylmethyl)carbamic acid t-butyl ester 
• 26177-43-5 3-nitrobenzylamine hydrochloride 
• 180002-02-2 tert-butyl methyl(3-nitrobenzyl)carbamate 

Relevant articles and documents

Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent

Pragmatic insertion of pargyline, a LSD1 inhibitor, as a surface recognition part in the HDAC inhibitory pharmacophore was planned in pursuit of furnishing potent antiprostate cancer agents. Resultantly, compound 14 elicited magnificent cell growth inhibi

MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

The present invention relates generally to novel macrocycles of Formula (I) or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, C, D, L, M, W, Z1, Z2, Z3, Z4, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

AMINE COMPOUNDS

The present invention provide a compound of the formula:wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrogen atom, etc.; R4 and R5 are the same or different and each represents a hydrogen, etc.; R6 represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.